Invuity (NASDAQ:IVTY) announced its quarterly earnings data on Tuesday. The medical instruments supplier reported ($0.43) EPS for the quarter, beating the Thomson Reuters’ consensus estimate of ($0.50) by $0.07, Bloomberg Earnings reports. Invuity had a negative return on equity of 212.38% and a negative net margin of 111.43%. The business had revenue of $11.23 million for the quarter, compared to the consensus estimate of $11.84 million.

Shares of Invuity (NASDAQ:IVTY) traded down $0.55 during mid-day trading on Wednesday, hitting $3.95. The stock had a trading volume of 479,800 shares, compared to its average volume of 291,645. Invuity has a 1 year low of $3.75 and a 1 year high of $9.70. The company has a quick ratio of 2.47, a current ratio of 2.90 and a debt-to-equity ratio of 5.39. The company has a market capitalization of $77.13, a PE ratio of -1.60 and a beta of -0.50.

IVTY has been the topic of several research analyst reports. Piper Jaffray Companies restated a “buy” rating and issued a $12.00 price objective on shares of Invuity in a research report on Friday, November 10th. Zacks Investment Research downgraded Invuity from a “hold” rating to a “sell” rating in a research report on Wednesday, January 10th. Finally, Northland Securities restated a “buy” rating and issued a $6.00 price objective on shares of Invuity in a research report on Wednesday. One investment analyst has rated the stock with a sell rating, one has issued a hold rating and four have assigned a buy rating to the company’s stock. The company currently has a consensus rating of “Buy” and an average price target of $8.50.

ILLEGAL ACTIVITY WARNING: “Invuity (IVTY) Posts Quarterly Earnings Results, Beats Estimates By $0.07 EPS” was originally posted by The Cerbat Gem and is the property of of The Cerbat Gem. If you are reading this report on another site, it was stolen and republished in violation of United States & international copyright legislation. The legal version of this report can be viewed at https://www.thecerbatgem.com/2018/02/14/invuity-ivty-posts-quarterly-earnings-results-beats-estimates-by-0-07-eps.html.

About Invuity

Invuity, Inc, a medical technology company, develops various surgical devices to address various surgical procedures in the United States. The company integrates its intelligent photonics technology platform into its single-use and reusable advanced surgical devices to address various critical intracavity illumination and visualization challenges.

Earnings History for Invuity (NASDAQ:IVTY)

Receive News & Ratings for Invuity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Invuity and related companies with MarketBeat.com's FREE daily email newsletter.